 |
ROBERT J. SPIEGEL, M.D., FACP
Senior Vice President, Medical Affairs and
Chief Medical Officer
Schering-Plough Research Institute
Schering-Plough Corporation
Kenilworth, New Jersey
Robert J. Spiegel, M.D., FACP, is Chief Medical Officer and senior
vice president at Schering-Plough Research Institute, the pharmaceutical
research arm of Schering-Plough Corporation. Dr. Spiegel has direct
responsibility for Global Pharmacovigilance and Clinical Quality Management
systems.
He is chair of Schering-Plough's Clinical & Preclinical Safety Surveillance
Committee (CPSSC). Prior to his current position, Dr. Spiegel was senior
vice president, Clinical Research.
Dr. Spiegel has published more than 70 scientific papers and serves
on the board of directors of Cancer Care, Inc. and the Cancer Institute
of New Jersey. He has special research interest in biological approaches
to cancer therapy. Dr. Spiegel received a B.A. at Yale University and
an M.D. at the University of Pennsylvania. He completed a fellowship
in medical oncology at the National Cancer Institute, NIH. Before joining
Schering Corporation in 1983, he served as director of the Developmental
Therapeutics Program at New York University Cancer Center and as assistant
professor at New York University Medical Center (Department of Medicine).
He remains an adjunct assistant professor at NYU.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.
|
|
